BGLAF
Price
$10.42
Change
+$0.84 (+8.77%)
Updated
Jul 29 closing price
Capitalization
1.18B
SNOA
Price
$4.06
Change
-$0.02 (-0.49%)
Updated
Sep 25 closing price
Capitalization
6.67M
Interact to see
Advertisement

BGLAF vs SNOA

Header iconBGLAF vs SNOA Comparison
Open Charts BGLAF vs SNOABanner chart's image
Biogaia AB
Price$10.42
Change+$0.84 (+8.77%)
Volume$1K
Capitalization1.18B
Sonoma Pharmaceuticals
Price$4.06
Change-$0.02 (-0.49%)
Volume$15.77K
Capitalization6.67M
BGLAF vs SNOA Comparison Chart in %
Loading...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGLAF vs. SNOA commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLAF is a Hold and SNOA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BGLAF: $10.42 vs. SNOA: $4.06)
Brand notoriety: BGLAF and SNOA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BGLAF: 85% vs. SNOA: 1%
Market capitalization -- BGLAF: $1.18B vs. SNOA: $6.67M
BGLAF [@Pharmaceuticals: Generic] is valued at $1.18B. SNOA’s [@Pharmaceuticals: Generic] market capitalization is $6.67M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGLAF’s FA Score shows that 1 FA rating(s) are green whileSNOA’s FA Score has 0 green FA rating(s).

  • BGLAF’s FA Score: 1 green, 4 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, BGLAF is a better buy in the long-term than SNOA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNOA’s TA Score shows that 2 TA indicator(s) are bullish.

  • SNOA’s TA Score: 2 bullish, 6 bearish.

Price Growth

BGLAF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SNOA (@Pharmaceuticals: Generic) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGLAF($1.18B) has a higher market cap than SNOA($6.67M). SNOA YTD gains are higher at: 50.929 vs. BGLAF (8.768). BGLAF has higher annual earnings (EBITDA): 393M vs. SNOA (-3.5M). BGLAF has more cash in the bank: 622M vs. SNOA (3.61M). BGLAF has higher revenues than SNOA: BGLAF (1.44B) vs SNOA (14.9M).
BGLAFSNOABGLAF / SNOA
Capitalization1.18B6.67M17,626%
EBITDA393M-3.5M-11,238%
Gain YTD8.76850.92917%
P/E Ratio34.39N/A-
Revenue1.44B14.9M9,664%
Total Cash622M3.61M17,254%
Total DebtN/A675K-
FUNDAMENTALS RATINGS
SNOA: Fundamental Ratings
SNOA
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
52
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGLAFSNOA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
23%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
23%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAIOX8.37N/A
N/A
PGIM Jennison Intl Sm-Md Cap Opps R6
DCGVX42.50N/A
N/A
BNY Mellon Dynamic Value Fund C
CAPSX9.24N/A
N/A
Federated Hermes Capital Income IS
EMREX20.85N/A
N/A
JPMorgan Emerging Mkts Rsrch Enh Eq I
TEOJX10.57N/A
N/A
Transamerica Emerging Markets Eq I2

BGLAF and

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
-0.49%
CTTH - BGLAF
28%
Poorly correlated
+3.64%
SHPH - BGLAF
8%
Poorly correlated
-6.22%
SDZXF - BGLAF
5%
Poorly correlated
N/A
TSNDF - BGLAF
3%
Poorly correlated
-12.47%
More

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and BNXTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and BNXTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
-0.49%
BNXTF - SNOA
29%
Poorly correlated
N/A
BGLAF - SNOA
27%
Poorly correlated
N/A
AKAN - SNOA
25%
Poorly correlated
-11.96%
CRDL - SNOA
24%
Poorly correlated
-0.92%
CGC - SNOA
24%
Poorly correlated
-3.52%
More